Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Bifidobacterium lactis Bb-02 and Reduced Inflammation

Research synthesisLow evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all 3 reported beneficial effects on inflammation markers, with predominantly small effect sizes. Evidence comes from populations including type 2 diabetes, gestational diabetes mellitus, and neurodegenerative diseases. Study doses and durations were not consistently reported.

  • Studied populations: people with type 2 diabetes, women with gestational diabetes, patients with neurodegenerative diseases

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests.

Generated Jul 12, 2026
3 of 3 papers
Back to top